Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a clinical‑stage biotech focused on developing non‑opioid pain therapeutics that target the core mechanisms of pain transduction. Leveraging a proprietary in‑house platform, the company applies advanced AI, machine learning, structure‑based, and knowledge‑based design to create highly potent, selective molecules against human genetics‑validated targets. This data‑driven, precision‑medicine approach positions Latigo as a leader in next‑generation analgesic discovery. The company is supported by leading venture partners such as Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
We are seeking an experienced and strategic Director of Drug Product Development to lead and oversee the development of drug product formulations for small molecules, from early clinical phases through commercialization.
Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a clinical‑stage biotech focused on developing non‑opioid pain therapeutics that target the core mechanisms of pain transduction. Leveraging a proprietary in‑house platform, the company applies advanced AI, machine learning, structure‑based, and knowledge‑based design to create highly potent, selective molecules against human genetics‑validated targets. This data‑driven, precision‑medicine approach positions Latigo as a leader in next‑generation analgesic discovery. The company is supported by leading venture partners such as Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
Fulcrum Therapeutics